TCR-Redirected T Cells Therapy in Patient With HBV Related HCC

Clinical trial NCT03899415 · UNKNOWN

Trial details

NCT number: NCT03899415
Sponsor: Beijing 302 Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2019-04-20
Primary completion: 2022-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.